v3.26.1
Capital Stock
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Capital Stock Capital Stock
Preferred Stock - The Company has authorized 100,000 shares of $50 par value 4.5% cumulative preferred nonvoting stock, which is callable at $52.50. There were 71,340 shares issued and 52,998 shares held in treasury at both March 31, 2026, and December 31, 2025. The Treasury shares at cost line in the unaudited Condensed Consolidated Balance Sheets includes $1.8 million related to preferred stock. There were no shares of preferred stock purchased and subsequently held in treasury during the three months ended March 31, 2026, or 2025. The Company has also authorized 1,000,000 shares of $10 par value second cumulative preferred voting stock. No shares have been issued as of March 31, 2026, or December 31, 2025.
Common Stock - The Company has authorized 180,000,000 shares of no par value common stock. There were 62,081,391 shares issued as of March 31, 2026, and December 31, 2025. No new shares were issued during the three months ended March 31, 2026, or 2025. There were 38,731,722 and 38,912,629 shares outstanding at March 31, 2026, and December 31, 2025, respectively.
Treasury Shares - The Company's 2026 stock repurchase program authorizes up to $500.0 million to repurchase MSA common stock in the open market and in private transactions. The stock repurchase program has no expiration date. The maximum number of shares that may be repurchased is calculated based on the dollars remaining under the program and the respective month-end closing share price. During the three months ended March 31, 2026, and 2025, the Company repurchased 277,270 and 62,125 shares, respectively, under this and the prior stock repurchase program. There were 23,349,669 and 23,168,762 treasury shares at March 31, 2026, and December 31, 2025, respectively.
The Company issues treasury shares for all stock-based benefit plans. Shares are issued from treasury at the average treasury share cost on the date of the transaction. There were 150,196 and 153,734 Treasury shares issued for these purposes during the three months ended March 31, 2026, and 2025, respectively.
Common stock activity is summarized as follows:
Three Months Ended March 31, 2026Three Months Ended March 31, 2025
(In thousands)Common
Stock
Treasury
Cost(a)
Common
Stock
Treasury
Cost(a)
Balance at beginning of period$343,842 $(483,248)$329,953 $(396,604)
Stock compensation expense3,812 — 2,629 — 
Restricted and performance stock awards(3,338)3,338 (2,642)2,642 
Stock options exercised12 10 137 93 
Treasury shares purchased for stock compensation programs— (9,847)— (8,347)
Share repurchase program— (50,447)— (9,996)
Balance at end of period$344,328 $(540,194)$330,077 $(412,212)
(a)Excludes treasury cost related to preferred stock.